Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Express Scripts
Harvard Business School
US Department of Justice
US Army
Federal Trade Commission

Generated: November 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,817,655

« Back to Dashboard

Summary for Patent: 5,817,655

Title: Methods of treatment using a thieno-benzodiazepine
Abstract:2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno -[2,3-b][1,5]benzodiazepine, or an acid salt thereof, has pharmaceutical properties, and is of particular use in the treatment of disorders of the central nervous system. The compound has the following structure: ##STR1##
Inventor(s): Chakrabarti; Jiban Kumar (Camberley, GB2), Hotten; Terrence Micharl (Farnborough, GB2), Tupper; David Edward (Reading, GB2)
Assignee: Eli Lilly and Company (Indianapolis, IN) Eli Lilly and Company Limited (Basingstoke, GB2)
Application Number:08/748,292
Patent Claim Types:
see list of patent claims

No matches for this query

International Patent Family for Patent: 5,817,655

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Spain2078440► Subscribe
European Patent Office0454436► SubscribeCA 2001 00042Denmark► Subscribe
European Patent Office0454436► SubscribeC970015Netherlands► Subscribe
European Patent Office0454436► SubscribeSPC/GB96/058United Kingdom► Subscribe
European Patent Office0454436► Subscribe97C0012Belgium► Subscribe
European Patent Office0454436► Subscribe9/1997Austria► Subscribe
Denmark0454436► Subscribe
Germany69112895► Subscribe
Latvia10262► Subscribe
Luxembourg90869► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Federal Trade Commission
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus